MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer.

Shaobo BaiYang SunYing ChengWeiliang YeChenchao JiangMiao LiuQifeng JiBangle ZhangQibing MeiDaozhou LiuSi-Yuan Zhou

Published in: Journal of nanobiotechnology (2021)

PSVII@MCP-CaP has great potential in the treatment of drug-resistant colon cancer. This study also explores a new method to prepare active targeting calcium phosphate nanoparticles loaded with a fat and water insoluble compound in water.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
cancer therapy
adipose tissue
drug delivery
cystic fibrosis
climate change
human health
walled carbon nanotubes
wound healing
replacement therapy
smoking cessation